These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 15378514

  • 21. Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3.
    Yamamoto-Watanabe Y, Watanabe M, Jackson M, Akimoto H, Sugimoto K, Yasujima M, Wakasaya Y, Matsubara E, Kawarabayashi T, Harigaya Y, Lyndon AR, Shoji M.
    Brain Res; 2010 Nov 18; 1361():140-5. PubMed ID: 20849835
    [Abstract] [Full Text] [Related]

  • 22. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Acta Neurol Scand; 2006 Sep 18; 114(3):205-9. PubMed ID: 16911350
    [Abstract] [Full Text] [Related]

  • 23. [Study on the concentration of 5-hydroxyindoleacetic acid (5-HIAA) in the lumbar cerebrospinal fluid (CSF) in neurological diseases].
    Fukuda H, Nakamura S, Hara K, Udaka F, Kameyama M.
    Rinsho Shinkeigaku; 1989 Sep 18; 29(9):1192-4. PubMed ID: 2480863
    [Abstract] [Full Text] [Related]

  • 24. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
    Isobe C, Murata T, Sato C, Terayama Y.
    Life Sci; 2005 Aug 26; 77(15):1836-43. PubMed ID: 15935398
    [Abstract] [Full Text] [Related]

  • 25. Cerebrospinal fluid choline levels are decreased in Parkinson's disease.
    Manyam BV, Giacobini E, Colliver JA.
    Ann Neurol; 1990 Jun 26; 27(6):683-5. PubMed ID: 2360805
    [Abstract] [Full Text] [Related]

  • 26. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.
    Grossman M, Farmer J, Leight S, Work M, Moore P, Van Deerlin V, Pratico D, Clark CM, Coslett HB, Chatterjee A, Gee J, Trojanowski JQ, Lee VM.
    Ann Neurol; 2005 May 26; 57(5):721-9. PubMed ID: 15852395
    [Abstract] [Full Text] [Related]

  • 27. Blood-based neurochemical diagnosis of vascular dementia: a pilot study.
    Bibl M, Esselmann H, Mollenhauer B, Weniger G, Welge V, Liess M, Lewczuk P, Otto M, Schulz JB, Trenkwalder C, Kornhuber J, Wiltfang J.
    J Neurochem; 2007 Oct 26; 103(2):467-74. PubMed ID: 17662050
    [Abstract] [Full Text] [Related]

  • 28. Magnetic resonance imaging and magnetic resonance spectroscopy in a patient with amyotrophic lateral sclerosis and frontotemporal dementia.
    Sarac H, Zagar M, Vranjes D, Henigsberg N, Bilić E, Pavlisa G.
    Coll Antropol; 2008 Jan 26; 32 Suppl 1():205-10. PubMed ID: 18405084
    [Abstract] [Full Text] [Related]

  • 29. Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes.
    Strekalova H, Buhmann C, Kleene R, Eggers C, Saffell J, Hemperly J, Weiller C, Müller-Thomsen T, Schachner M.
    Neurobiol Aging; 2006 Jan 26; 27(1):1-9. PubMed ID: 16298234
    [Abstract] [Full Text] [Related]

  • 30. Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Rentzos M, Paraskevas GP, Kapaki E, Nikolaou C, Zoga M, Rombos A, Tsoutsou A, Vassilopoulos D D.
    J Neurol Sci; 2006 Nov 15; 249(2):110-4. PubMed ID: 16843497
    [Abstract] [Full Text] [Related]

  • 31. Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies.
    Mollenhauer B, Steinacker P, Bahn E, Bibl M, Brechlin P, Schlossmacher MG, Locascio JJ, Wiltfang J, Kretzschmar HA, Poser S, Trenkwalder C, Otto M.
    Neurodegener Dis; 2007 Nov 15; 4(5):366-75. PubMed ID: 17622779
    [Abstract] [Full Text] [Related]

  • 32. Biological markers in cerebrospinal fluid (CSF) and evaluation of in vitro effect of CSF on PC12 cell line viability in Alzheimer's disease.
    Yaka E, Egrilmez MY, Keskinoglu P, Cavdar Z, Genc S, Genc K, Iyilikci L, Yener GG.
    Cell Biochem Funct; 2009 Aug 15; 27(6):395-401. PubMed ID: 19639578
    [Abstract] [Full Text] [Related]

  • 33. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
    Palumbo B, Siepi D, Sabalich I, Tranfaglia C, Parnetti L.
    Funct Neurol; 2008 Aug 15; 23(2):93-6. PubMed ID: 18671910
    [Abstract] [Full Text] [Related]

  • 34. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
    Yin GN, Lee HW, Cho JY, Suk K.
    Brain Res; 2009 Apr 10; 1265():158-70. PubMed ID: 19368810
    [Abstract] [Full Text] [Related]

  • 35. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
    Watanabe T, Shiino A, Akiguchi I.
    Dement Geriatr Cogn Disord; 2008 Apr 10; 26(1):89-100. PubMed ID: 18617735
    [Abstract] [Full Text] [Related]

  • 36. [Regional cerebral blood flow and cerebrospinal fluid amino acid analysis in elderly dementia].
    Oishi M, Mochizuki Y, Sanuki E.
    No To Shinkei; 1998 Nov 10; 50(11):1018-21. PubMed ID: 9866128
    [Abstract] [Full Text] [Related]

  • 37. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Scand J Clin Lab Invest; 2007 Nov 10; 67(3):264-9. PubMed ID: 17454840
    [Abstract] [Full Text] [Related]

  • 38. Parkinson's disease and benign essential tremor: somatostatin-like immunoreactivity in the cerebrospinal fluid.
    Christensen SE, Dupont E, Mondrup K, Olivarius BF, Orskov H.
    Adv Neurol; 1984 Nov 10; 40():325-31. PubMed ID: 6229980
    [No Abstract] [Full Text] [Related]

  • 39. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kaufmann E, Boehm BO, Süssmuth SD, Kientsch-Engel R, Sperfeld A, Ludolph AC, Tumani H.
    Neurosci Lett; 2004 Nov 23; 371(2-3):226-9. PubMed ID: 15519762
    [Abstract] [Full Text] [Related]

  • 40. Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Jiménez-Jiménez FJ, Hernánz A, Medina-Acebrón S, de Bustos F, Zurdo JM, Alonso H, Puertas I, Barcenilla B, Sayed Y, Cabrera-Valdivia F.
    Acta Neurol Scand; 2005 Feb 23; 111(2):114-7. PubMed ID: 15644071
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.